GlassScriptPhysician profile
Shawna Grimm
NPI 1225285125
$10,816.43
in general payments reported to CMS, 2019-2025
18 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,300 · 2020: $74.81 · 2021: $1,204 · 2022: $1,488 · 2023: $1,406 · 2024: $71.44 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172 · Travel and Lodging: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.89 |
| Travel and Lodging | $578.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,172.39 | 2019-2023 | Da Vinci Surgical System |
| Bard Access Systems, INC. | $118.91 | 2019 | |
| Baxter Healthcare | $88.91 | 2021-2023 | Perclot |
| Smith+Nephew, INC. | $63.61 | 2023-2025 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| Tela Bio, INC. | $51.73 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Braintree Laboratories, INC. | $48.04 | 2020-2023 | Suflave, Sutab |
| Regeneron Healthcare Solutions, INC. | $38.10 | 2025 | Lynozyfic |
| W. L. Gore & Associates, INC. | $36.85 | 2024 | Gore Synecor Biomaterial |
| Incyte Corporation | $28.17 | 2025 | Monjuvi, Zynyz |
| Astrazeneca Pharmaceuticals LP | $27.40 | 2025 | |
| Novartis Pharmaceuticals Corporation | $26.15 | 2025 | |
| Solventum Corporation | $19.62 | 2025 | V.A.C.Ulta, Prevena |
| Exelixis INC. | $19.48 | 2025 | Cabometyx |
| Organogenesis INC. | $18.94 | 2025 | Apligraf |
| Molli Surgical (US) INC | $17.49 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $17.10 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawna Grimm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.